Recall archive / FDA company announcement
Dexcom G7: Continuous Glucose Monitoring System — FDA announcement May 29, 2026
Published notice; closure not supplied
A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.
Source date May 29, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Continuous Glucose Monitoring System
- Reason
- Sensors identified as scrap were diverted and sold by third-party
- Classification
- Not supplied
- Recalling firm
- Dexcom, Inc.
- Quantity
- Not supplied
- Agency-reported status
- Company recall announcement
- Source record identifier
- 9840f9452ad6767d
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Users with sensors from affected Dexcom G7 lots (1725204004 and 1725069002) should not use those sensors and can call Dexcom Customer Support in the US at 1-844-478-1600 to request replacements. More information on how to determine if sensors are from an affected lot and what action to take is available at www.dexcom.com/theft-check. Dexcom is working to update this website with resources for users outside the US and will notify those users as soon as it is updated.; Lot 1725204004: Dexcom G7 sensors that are not properly sterilized have an increased risk of skin infection.; Lot 1725069002: Dexcom G7 sensors from a lot with an elevated internal testing failure rate have an increased risk of having no sensor readings available.; Media Contact | Investor Contact; James McIntosh | Sean Christensen; 959-716-6698 | 858-203-6657; [email protected] | [email protected] |
Match all identifying details in the current notice. A brand name alone is not enough.
Product tables from the announcement
These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.
| Media Contact | Investor Contact |
|---|---|
| James McIntosh | Sean Christensen |
| 959-716-6698 | 858-203-6657 |
| [email protected] | [email protected] |
Announcement retrieved Oct 1, 2026. Official announcement.
Distribution
Not supplied
No US distribution state could be established from this record. Check the official notice.
Dates in the source
- Fda listing date
- May 29, 2026
- Company announcement date
- May 26, 2026
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.